Sign in
Active, not recruitingNo phase

Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy

Key facts

Who runs it
Rocket Pharmaceuticals Inc.
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
9 people, planned
Started
1 Jun 2020
Expected to end
17 Jan 2034
Type of study
Observational
Treatments tested
  • Safety and efficacy assessments
Record updated
13 April 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (5)Hide the full registry criteria

Who can take part

  • Enrolled in the FANCOLEN-I study
  • Treated with gene therapy in the FANCOLEN-I study
  • Able to adhere to the study visit schedule and protocol requirements
  • Provided written informed consent and, as applicable, assent to participate

Who cannot take part

  • There are no exclusion criteria for this study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a long-term safety and efficacy follow-up study for subjects with Fanconi Anaemia Subtype A who have been treated with ex vivo gene therapy on the FANCOLEN-I trial. After completion of the FANCOLEN-I study, eligible subjects will be followed for a total of 15 years post gene therapy treatment. No investigational drug product will be administered during this study.

The group in the trial

  • Subjects with Fanconi Anaemia Subtype A (FA-A)

    Subjects treated with ex vivo lentiviral gene therapy product in FANCOLEN-I trial and agree to participate in this long-term follow-up (LTFU) study

    Treatment: Safety and efficacy assessments

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene in Patients With Fanconi Anaemia Subtype A: FANCOLEN-I
Publications
Record updated
13 April 2026